As osteopontin has T cell suppressive activity in other malignancies, our data implicate osteopontin as a potential regulator of anti-tumor immunity in canine and human HS, and identifies multiple other candidate genes with immunomodulatory potential [5, 6]. The gene discussed is SPP1; the disease is neoplasm.